PCN94 Cost-Effectiveness of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies fo ...
Dec 1, 2020, 00:00 AM
10.1016/j.jval.2020.08.231
https://www.valueinhealthjournal.com/article/S1098-3015(20)32487-6/fulltext
Section Title :
Section Order :
10181
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32487-6&doi=10.1016/j.jval.2020.08.231